• 2024-01-23
    C轮
    7500万美元
    Bristol-Myers Squibb
    Timefolio Capital
    Mirae Asset Capital Life Science
    Mirae Asset Venture Investments
    DROIA
    EcoR1 Capital
    Atlas Venture
    GV
    Johnson & Johnson Innovation
    The Column Group
    AbbVie Biotech Ventures
    The Mark Foundation for Cancer Research
    Mirae Asset Capital
  • 2020-04-23
    B轮
    6300万美元
    EcoR1 Capital
    GV
    The Column Group
    AbbVie Biotech Ventures
    The Mark Foundation for Cancer Research
  • 2018-05-18
    A轮
    4000万美元
    The Column Group
    Atlas Venture
    EcoR1 Capital